BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34444654)

  • 1. Indirect Predictors of Visceral Adipose Tissue in Women with Polycystic Ovary Syndrome: A Comparison of Methods.
    Kałużna M; Czlapka-Matyasik M; Bykowska-Derda A; Moczko J; Ruchala M; Ziemnicka K
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables.
    Swainson MG; Batterham AM; Tsakirides C; Rutherford ZH; Hind K
    PLoS One; 2017; 12(5):e0177175. PubMed ID: 28493988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index.
    Kogure GS; Ribeiro VB; Mendes MC; Ferriani RA; Furtado CLM; Dos Reis RM
    Arch Endocrinol Metab; 2023 May; 67(5):e000627. PubMed ID: 37249458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS.
    Techatraisak K; Wongmeerit K; Dangrat C; Wongwananuruk T; Indhavivadhana S
    Gynecol Endocrinol; 2016; 32(4):276-80. PubMed ID: 26503544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome.
    Zhang Y; Cai M; Dilimulati D; Lin Z; Sun H; Cui R; Fei H; Gao X; Zeng Q; Shao X; Zhang M; Qu S
    Front Endocrinol (Lausanne); 2021; 12():782808. PubMed ID: 35145476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
    Wang H; Cao H; Cao J; Zhang L
    Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
    Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
    Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women.
    Direk K; Cecelja M; Astle W; Chowienczyk P; Spector TD; Falchi M; Andrew T
    BMC Cardiovasc Disord; 2013 Apr; 13():25. PubMed ID: 23552273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of visceral adipose tissue in polycystic ovary syndrome: dual-energy X-ray absorptiometry versus magnetic resonance imaging.
    Frøssing S; Nylander MC; Chabanova E; Kistorp C; Skouby SO; Faber J
    Acta Radiol; 2018 Jan; 59(1):13-17. PubMed ID: 28534418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-energy X-ray absorptiometry and anthropometric estimates of visceral fat in Black and White South African Women.
    Micklesfield LK; Evans J; Norris SA; Lambert EV; Jennings C; Joffe Y; Levitt NS; Goedecke JH
    Obesity (Silver Spring); 2010 Mar; 18(3):619-24. PubMed ID: 19763094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.
    Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
    Ramezani Tehrani F; Minooee S; Azizi F
    Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of a new anthropometric indicator - VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome.
    Brończyk-Puzoń A; Jagielski P; Kulik-Kupka K; Koszowska A; Nowak J; Zubelewicz-Szkodzińska B
    Adv Clin Exp Med; 2017 Aug; 26(5):825-828. PubMed ID: 29068579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.
    Ribeiro VB; Kogure GS; Lopes IP; Silva RC; Pedroso DCC; Ferriani RA; Furtado CLM; Reis RMD
    Arch Endocrinol Metab; 2019 Jul; 63(4):417-426. PubMed ID: 31365630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
    Qing L; Wei R; Chan L; Xiaoya Z; Xin X
    J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.